Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

VTCN1 Antikörper

VTCN1 Reaktivität: Human, Maus WB, ELISA Wirt: Kaninchen Monoclonal unconjugated
Produktnummer ABIN1077428
  • Target Alle VTCN1 Antikörper anzeigen
    VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
    Reaktivität
    • 83
    • 21
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus
    Wirt
    • 70
    • 12
    • 2
    • 2
    Kaninchen
    Klonalität
    • 67
    • 18
    • 1
    Monoklonal
    Konjugat
    • 28
    • 11
    • 8
    • 5
    • 5
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Dieser VTCN1 Antikörper ist unkonjugiert
    Applikation
    • 55
    • 36
    • 31
    • 27
    • 26
    • 15
    • 8
    • 8
    • 7
    • 6
    • 5
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), ELISA
    Aufreinigung
    Affinity chromatography purified via peptide column
    Immunogen
    Rabbit polyclonal VTCN1 antibody was raised against an 18 amino acid peptide near the center of human VTCN1.
    Isotyp
    IgG
    Top Product
    Discover our top product VTCN1 Primärantikörper
  • Applikationshinweise
    VTCN1 antibody can be used for detection of VTCN1 by Western blot at 1 - 2 μg/mL.
    Kommentare

    (IN) V-set domain containing T cell activation inhibitor 1

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1 mg/mL
    Buffer
    PBS containing 0.02 % Sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    VTCN1 antibody can be stored at 4 °C for three months. At -20 °C stable for up to one year.
    Haltbarkeit
    12 months
  • Target
    VTCN1 (V-Set Domain Containing T Cell Activation Inhibitor 1 (VTCN1))
    Andere Bezeichnung
    VTCN1 (VTCN1 Produkte)
    Synonyme
    B7h4 antikoerper, B7s1 antikoerper, B7x antikoerper, BC032925 antikoerper, B7-H4 antikoerper, B7H4 antikoerper, B7S1 antikoerper, B7X antikoerper, B7h.5 antikoerper, PRO1291 antikoerper, VCTN1 antikoerper, RGD1311204 antikoerper, V set domain containing T cell activation inhibitor 1 L homeolog antikoerper, V-set domain containing T cell activation inhibitor 1 antikoerper, V-set domain containing T-cell activation inhibitor 1 antikoerper, V set domain containing T cell activation inhibitor 1 antikoerper, vtcn1.L antikoerper, VTCN1 antikoerper, vtcn1 antikoerper, Vtcn1 antikoerper
    Hintergrund
    T cell immunity plays a critical role in host immune surveillance of tumour cell growth and metastatic spread. VTCN1, also known as B7-H4, is a member of the B7 family of immune regulatory molecules. Expressed primarily on the membrane of lymphoid cells, VTCN1 is an immunoinhibitory protein that interacts with receptors on the surface of T lymphocytes, thus mediating cellular and humoral immune responses. Overexpression of VTCN1 is associated with certain malignancies, including ovarian and breast cancer, which may be a mechanism by which tumour cells suppress T cell immunity and facilitate tumour progression. VTCN1 may thus be a useful biomarker for the early detection of ovarian cancer.
    Synonyms: V-set domain containing T cell activation inhibitor 1, T cell costimulatory molecule B7x, B7-H4, B7H4, B7S1, B7X
    Molekulargewicht
    31 kDa (calculated)
    Gen-ID
    79679
    NCBI Accession
    NP_078902
Sie sind hier:
Kundenservice